Live audio of the webcast will be available on the “Investors” section of the company website at investors.cytekbio.com.

FREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- With cancer research and diagnostics driving the need for deeper, faster cellular insights, spectral flow cytometry leader Cytek Biosciences, Inc.

FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (CTKB) (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation ...

Analysts have provided the following ratings for Cytek Biosciences (NASDAQ:CTKB) within the last quarter: In the last 3 months, 4 analysts have offered 12-month price targets for Cytek Biosciences.

Cytek Biosciences (NASDAQ:CTKB) reported fourth-quarter and full-year 2025 results on Wednesday, describing a return to growth in the back half of the year amid what management characterized as a ...

Cytek Biosciences Inc. (NASDAQ:CTKB) is one of the 8 Best Life Sciences Penny Stocks to Buy. As of the April 8 closing, the consensus sentiment around Cytek Biosciences Inc. (NASDAQ:CTKB) remained ...

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Cytek Biosciences has seen ...

Cytek Biosciences, Inc. announced that it will report its financial results for the fourth quarter and full year 2024 on February 27, 2025, after market close. A conference call to discuss these ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded ...

FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results ...